UK to get 30 million vaccine doses if trials work

Oxford University had finalised a global licencing agreement with government support with AstraZeneca for the commercialisation and manufacturing of the vaccine. Britain business secretary Alok Sharma said that the first clinical trial for the COVID-19 vaccine was progressing well. Despite work on the vaccine he warned there were no certainties that one would be found.